|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Provision for credit losses | |||||
| Amortization (accretion) of right of use asset | |||||
| Equity security dividends reinvested | |||||
| Unrealized (gain) loss on equity security | |||||
| Write down of other real estate owned | |||||
| Non-cash compensation | |||||
| Loss on disposal of premises and equipment | |||||
| Gain of sale of SBA loans | |||||
| Gain on insurance proceeds | |||||
| Gain on premium call of debt security | |||||
| (Gain) on fair value hedge | |||||
| Gain on settlement of fair value hedge | |||||
| Deferred tax expense (benefit) | |||||
| Gain on sale of other real estate owned | |||||
| Loss on sale of securities | |||||
| Stock based compensation | |||||
| Amortization of debt issuance costs | |||||
| Amortization of premiums and (accretion of discounts), net | |||||
| Bank owned life insurance cash surrender value | |||||
| Increase in bank owned life insurance cash surrender value | |||||
| Deferred loan fees and costs, net | |||||
| Accrued interest payable | |||||
| Other liabilities | |||||
| Decrease (increase) in | |||||
| Mortgage loans held for sale | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Net cash provided by operating activities | |||||
| Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | |||||
| Available for sale | |||||
| Held to maturity | |||||
| Proceeds from sale of securities, held to maturity | |||||
| Redemption of certificates of deposit | |||||
| Loans made to customers, net of principal collected | |||||
| Proceeds from sale of loans | |||||
| Purchase of stock in FHLB of Atlanta | |||||
| Purchase of bank owned life insurance | |||||
| Equity security dividends reinvested | |||||
| Redemption/pay out of BOLI | |||||
| Proceeds from sale of REO property | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from insurance | |||||
| Purchases of premises, equipment and software | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Noninterest-bearing deposits | |||||
| Interest-bearing deposits | |||||
| Securities sold under repurchase agreements | |||||
| Federal Home Loan Bank of Atlanta advances | |||||
| Federal Reserve Bank advances | |||||
| Subordinated debt offering, net of issuance costs | |||||
| Long-term debt principal payments | |||||
| Dividends paid, net of reinvestments | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the period for interest | |||||
| Cash paid during the period for income taxes | |||||
| Supplemental disclosure of non-cash transactions: | |||||
| Net unrealized gain (loss) on securities available for sale | |||||
| Increase (decrease) in fair value of interest rate swap agreements | |||||
| Additions to right of use assets obtained in exchange for lease liabilities | |||||
| Foreclosure in settlement of loan receivable | |||||
Loading...